In vitro optimization of crushed drug-sensitive antituberculosis medication when administered via a nasogastric tube.

ABSTRACT:

Importance

The incidence of tuberculosis (TB) in intensive care units (ICUs) can be as high as 3% in high-burden settings, translating to more than 7,500 patients admitted to the ICU annually. In resource-limited settings, the lack or absence of intravenous formulations of drug-sensitive antituberculosis medications necessitates healthcare practitioners to crush, dissolve, and administer the drugs to critically ill patients via a nasogastric tube (NGT). This off-label practice has been linked to plasma concentrations below the recommended target concentrations, particularly of rifampicin and isoniazid, leading to clinical failure and the development of drug resistance. Optimizing the delivery of crushed drug-sensitive antituberculosis medication via the NGT to critically ill patien

SUBMITTER: Phogole CM 

PROVIDER: S-EPMC10871698 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature